CRC Press Green Synthesis in Nanomedicine and Human Health

Product Description Green synthesis is an emerging method for deriving nanoparticles present in natural plants for use in nanomedicine. Written by experts in the field, Green Synthesis in Nanomedicine and Human Health showcases the exciting developments of this specialty and its potential for promoting human health and well-being. This book gives practical information on novel preparation methods for identifying nanoparticles present in natural plants. It discusses applications of nanoparticles in combating communicable, non-communicable and vector-borne diseases. It also explores the potential for nanoparticles to combat antimicrobial resistance through improvements in treatment methods, diagnostics and drug delivery systems. Features scientific evidence of opportunities for integrating indigenous flora into nanomedicine to develop cost-effective therapeutic and diagnostic solutions for diseases, including cancer, tuberculosis, malaria and diabetes. Places green synthesis and nanomedicine in the African orthodox and traditional healthcare context. Provides policymakers with scientific evidence to inform policies for controlling or mitigating dangerous diseases. This book is essential reading for students, scientists, policymakers and practitioners of nanotechnology, and will appeal to anyone with an interest in integrating traditional African healthcare and Western medicine. About the Author Dr Steven Mufamadi is the founder and managing director of Nabio Consulting (Pty) Ltd. He has earned his PhD in (nano)pharmaceutics from Wits University, entrepreneurship short courses from University of Pretoria and Ecole Polytechique Federale de Lausanne (EPFL), Switzerland. His interest is in the health applications of nanotechnology, entrepreneurship and commercialization. He has authored and co-authored three patents, one of which is an international patent, several peer-reviewed scientific publications and book chapters. He was awarded the awards an international inventor by the Wits enterprise & Wits University Innovation Forum, and the best peer reviewed research paper of pharmaceutics (nanomedicine) by South African Academy of Pharmaceutical Sciences. In 2017, he was supported for UNESCO-Kalinga Prize for the popularization of nanotechnology in South Africa by the South African National Commission for UNESCO. From 2014, he is member of the national nanotechnologies committee (ISO TC229) at the South African Bureau of Standards (SABS). Dr Rofhiwa Bridget Mulaudzi holds a PhD degree in Ethnobotany and MSc in Botany from the University of KwaZulu-Natal. She holds an Honours degree in Biochemistry and BSc degree in Biochemistry and Microbiology from the University of Venda and  is registered with the South African Council for Natural Scientific Professions (SACNASP) as a Professional Natural Scientist. Apart from university degrees, Rofhiwa completed a formal certificate courses  in Basic, Intermediate and Advanced Project Management at University of South Africa and a Certificate in Bio-Entrepreneurship Training Programme at Coach Lab, the Innovation Hub, Pretoria, South Africa. Dr Mulaudzi was a Researcher in Medicinal Plants at the Agricultural Research Council. Her current research projects are focusing on the Research and Development (R&D) of both medicinal plants and indigenous vegetables as medicine for human health and wellbeing. Dr Mulaudzi has published 14 peer reviewed articles in international journals and contributed chapters to books. Her current research interests include development of nanomedicine drugs using African indigenous plants and using African leafy vegetables as source of medicine. She is currently a Researcher/Consultant in natural plants/products at Romukhu (Pty) Ltd, and COO at Anwa Laboratories (Pty) Ltd under the Pecolo Group. Dr Richard Lander Kwame Glover (Pr. Nat. Sci.) is a Biological Scientist with a bias in Food Microbiology. Dr Glover worked as a Research Officer at the Cent